663 related articles for article (PubMed ID: 27724968)
1. Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells.
Page S; Munsell A; Al-Ahmad AJ
Fluids Barriers CNS; 2016 Oct; 13(1):16. PubMed ID: 27724968
[TBL] [Abstract][Full Text] [Related]
2. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
3. Oxygen-Glucose Deprivation/Reoxygenation-Induced Barrier Disruption at the Human Blood-Brain Barrier is Partially Mediated Through the HIF-1 Pathway.
Page S; Raut S; Al-Ahmad A
Neuromolecular Med; 2019 Dec; 21(4):414-431. PubMed ID: 30911877
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of a mouse cerebral microvascular endothelial cell line (bEnd.3) after oxygen glucose deprivation and reoxygenation.
Ku JM; Taher M; Chin KY; Grace M; McIntyre P; Miller AA
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):777-86. PubMed ID: 27128638
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MicroRNA-155 Supports Endothelial Tight Junction Integrity Following Oxygen-Glucose Deprivation.
Pena-Philippides JC; Gardiner AS; Caballero-Garrido E; Pan R; Zhu Y; Roitbak T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945912
[TBL] [Abstract][Full Text] [Related]
6. In vitro model of cerebral ischemia by using brain microvascular endothelial cells derived from human induced pluripotent stem cells.
Kokubu Y; Yamaguchi T; Kawabata K
Biochem Biophys Res Commun; 2017 Apr; 486(2):577-583. PubMed ID: 28336435
[TBL] [Abstract][Full Text] [Related]
7. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.
Allen C; Srivastava K; Bayraktutan U
Stroke; 2010 Sep; 41(9):2056-63. PubMed ID: 20651275
[TBL] [Abstract][Full Text] [Related]
8. Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties.
Patel R; Alahmad AJ
Fluids Barriers CNS; 2016 Apr; 13():6. PubMed ID: 27068644
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.
Yang T; Roder KE; Abbruscato TJ
J Pharm Sci; 2007 Dec; 96(12):3196-213. PubMed ID: 17828743
[TBL] [Abstract][Full Text] [Related]
10. Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation.
Katt ME; Linville RM; Mayo LN; Xu ZS; Searson PC
Fluids Barriers CNS; 2018 Feb; 15(1):7. PubMed ID: 29463314
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-glucose deprivation and reoxygenation as an in vitro ischemia-reperfusion injury model for studying blood-brain barrier dysfunction.
Alluri H; Anasooya Shaji C; Davis ML; Tharakan B
J Vis Exp; 2015 May; (99):e52699. PubMed ID: 25992584
[TBL] [Abstract][Full Text] [Related]
12. Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.
Lee CAA; Seo HS; Armien AG; Bates FS; Tolar J; Azarin SM
Fluids Barriers CNS; 2018 Apr; 15(1):9. PubMed ID: 29615068
[TBL] [Abstract][Full Text] [Related]
13. Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.
So G; Nakagawa S; Morofuji Y; Hiu T; Hayashi K; Tanaka K; Suyama K; Deli MA; Nagata I; Matsuo T; Niwa M
Cell Mol Neurobiol; 2015 May; 35(4):563-72. PubMed ID: 25547389
[TBL] [Abstract][Full Text] [Related]
14. Effects of preconditioning on tight junction and cell adhesion of cerebral endothelial cells.
An P; Xue YX
Brain Res; 2009 May; 1272():81-8. PubMed ID: 19332028
[TBL] [Abstract][Full Text] [Related]
15. A human pluripotent stem cell-derived in vitro model of the blood-brain barrier in cerebral malaria.
Gopinadhan A; Hughes JM; Conroy AL; John CC; Canfield SG; Datta D
Fluids Barriers CNS; 2024 May; 21(1):38. PubMed ID: 38693577
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol strengthens barrier integrity in brain endothelial cells.
Horai S; Nakagawa S; Tanaka K; Morofuji Y; Couraud PO; Deli MA; Ozawa M; Niwa M
Cell Mol Neurobiol; 2013 Mar; 33(2):291-307. PubMed ID: 23224787
[TBL] [Abstract][Full Text] [Related]
18. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils block permeability increases induced by oxygen glucose deprivation in a culture model of the human blood-brain barrier.
Cowan KM; Easton AS
Brain Res; 2010 May; 1332():20-31. PubMed ID: 20346925
[TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway.
Yang G; Qian C; Wang N; Lin C; Wang Y; Wang G; Piao X
Cell Mol Neurobiol; 2017 May; 37(4):619-633. PubMed ID: 27380043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
